Cucurbitacin IIb improved active chromatin‐induced systemic lupus erythematosus via balancing the percentage of Th17 and Treg cells
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cucurbitacin IIb improved active chromatin‐induced systemic lupus erythematosus via balancing the percentage of Th17 and Treg cells
Authors
Keywords
-
Journal
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-10-31
DOI
10.1111/1440-1681.13434
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Seroconversion to antinuclear antibody negativity and its association with disease flare in patients with systemic lupus erythematosus
- (2020) Oh Chan Kwon et al. LUPUS
- Cucurbitacin IIb, a steroidal triterpene from Ibervillea sonorae induces antiproliferative and apoptotic effects on cervical and lung cancer cells
- (2020) Heriberto Torres-Moreno et al. STEROIDS
- T Cell Metabolism: A New Perspective on Th17/Treg Cell Imbalance in Systemic Lupus Erythematosus
- (2020) Juan Shan et al. Frontiers in Immunology
- Regulatory T-cell levels in systemic lupus erythematosus patients: a meta-analysis
- (2019) Y Zhu et al. LUPUS
- Management strategies and future directions for systemic lupus erythematosus in adults
- (2019) Laura Durcan et al. LANCET
- Restoring T-helper 17 cell/regulatory T-cell balance and decreasing disease activity by rapamycin and all-trans retinoic acid in patients with systemic lupus erythematosus
- (2019) Y Chu et al. LUPUS
- Vasoactive intestinal peptide ameliorates renal injury in a pristane-induced lupus mouse model by modulating Th17/Treg balance
- (2019) Dongdong Fu et al. BMC Nephrology
- Cucurbitacin IIa interferes with EGFR-MAPK signaling pathway leads to proliferation inhibition in A549 cells
- (2019) Jie Zhang et al. FOOD AND CHEMICAL TOXICOLOGY
- High genetic risk score is associated with early disease onset, damage accrual and decreased survival in systemic lupus erythematosus
- (2019) Sarah Reid et al. ANNALS OF THE RHEUMATIC DISEASES
- Emerging Targets for the Treatment of Lupus Erythematosus: There is No Royal Road to Treating Lupus
- (2018) Shinsuke Yasuda Modern Rheumatology
- Soluble MHC class II-driven therapy for a systemic lupus erythematosus murine experimental in vitro and in vivo model
- (2018) K. Bakela et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Aberrant T Cell Signaling and Subsets in Systemic Lupus Erythematosus
- (2018) Takayuki Katsuyama et al. Frontiers in Immunology
- Update on the epidemiology, risk factors, and disease outcomes of systemic lupus erythematosus
- (2018) Irini Gergianaki et al. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
- Systemic lupus erythematosus: Diagnosis and clinical management
- (2018) Andrea Fava et al. JOURNAL OF AUTOIMMUNITY
- Allogeneic adipose-derived stem cells suppress mTORC1 pathway in a murine model of systemic lupus erythematosus
- (2018) S. Wei et al. LUPUS
- CKD-506, a novel HDAC6-selective inhibitor, improves renal outcomes and survival in a mouse model of systemic lupus erythematosus
- (2018) Eun Wha Choi et al. Scientific Reports
- Regulation of T Cell Activation and Differentiation by Extracellular Vesicles and Their Pathogenic Role in Systemic Lupus Erythematosus and Multiple Sclerosis
- (2017) Cristina Ulivieri et al. MOLECULES
- Systemic lupus erythematosus
- (2016) Arvind Kaul et al. Nature Reviews Disease Primers
- Immune Regulation of Metabolic Homeostasis in Health and Disease
- (2015) Jonathan R. Brestoff et al. CELL
- The regulation of the Treg/Th17 balance by mesenchymal stem cells in human systemic lupus erythematosus
- (2015) Dandan Wang et al. Cellular & Molecular Immunology
- Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity
- (2015) Roba M. Talaat et al. CYTOKINE
- Cucurbitacin IIb Exhibits Anti-Inflammatory Activity through Modulating Multiple Cellular Behaviors of Mouse Lymphocytes
- (2014) Yao Wang et al. PLoS One
- Anti-proliferative effect of 23,24-dihydrocucurbitacin F on human prostate cancer cells through induction of actin aggregation and cofilin-actin rod formation
- (2012) Shuai Ren et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Adaptive immunity in obesity and insulin resistance
- (2012) Henrike Sell et al. Nature Reviews Endocrinology
- Effects of cucurbitacins on cell morphology are associated with sensitization of renal carcinoma cells to TRAIL-induced apoptosis
- (2011) Curtis J. Henrich et al. APOPTOSIS
- Cucurbitacin: Ancient Compound Shedding New Light on Cancer Treatment
- (2011) Dhong Hyun Lee et al. TheScientificWorldJOURNAL
- Pharmacotherapy of systemic lupus erythematosus
- (2009) Lisa Francis et al. EXPERT OPINION ON PHARMACOTHERAPY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started